Maria Rovithi

20142019
If you made any changes in Pure these will be visible here soon.

Research Output 2014 2019

Filter
Meeting Abstract
2017

A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Rovithi, M., Labots, M., Richard, Honeywell, Ten Tije, A. J., Ruijter, R., Skardhamar, M., Peters, G. J., Voortman, J. & Verheul, H. M. W., 20 May 2017, In : Journal of Clinical Oncology. 35

Research output: Contribution to journalMeeting AbstractAcademic

2014

High-dose, intermittent sunitinib as an alternative treatment strategy

Rovithi, M., de Haas, R. R., Honeywell, R. J., Voortman, J., Griffioen, A. W., Labots, M., Luik, A. M., Peters, G. J., Broxterman, H. J. & Verheul, H. M. W., 1 Oct 2014, In : Cancer Research. 74, 19

Research output: Contribution to journalMeeting AbstractAcademic